Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 473001 - 473020 out of 476480 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L04AC02) basiliximab (adm: P, course dose) | SIMULECT 10MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | NovartisPharmaceuticalsCorporation |
USA | (L04AC02) basiliximab (adm: P, course dose) | SIMULECT 20MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | NovartisPharmaceuticalsCorporation |
USA | (L04AC02) basiliximab (adm: P, course dose) | SIMULECT 20MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | NovartisPharmaceuticalsCorporation |
USA | (L04AC03) anakinra (adm: P) | KINERET 100MG/0.67ML INJ,SYRINGE | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection | Sobi,Inc. |
USA | (L04AC03) anakinra (adm: P) | KINERET 100MG/0.67ML INJ,SYRINGE | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection | Sobi,Inc. |
USA | (L04AC04) rilonacept (adm: P) | ARCALYST 220MG VIL | 1X4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | KiniksaPharmaceuticals(UK),Ltd. |
USA | (L04AC04) rilonacept (adm: P) | ARCALYST 220MG VIL | 1X4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | KiniksaPharmaceuticals(UK),Ltd. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 130MG/26ML IV VIAL | 1X26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 130MG/26ML IV VIAL | 1X26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 45MG/0.5ML PFS (ULTRA-SAFE) | 1X45MG/0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 45MG/0.5ML PFS (ULTRA-SAFE) | 1X45MG/0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 45MG/0.5ML SOLN | 1X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 45MG/0.5ML SOLN | 1X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 90MG/ML PFS (ULTRA-SAFE) | 1X90MG/1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC05) ustekinumab (adm: P) | STELARA 90MG/ML PFS (ULTRA-SAFE) | 1X90MG/1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 200MG/10ML VIAL | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 200MG/10ML VIAL | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 400MG/20ML VIAL | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 400MG/20ML VIAL | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 80MG/4ML VIAL | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |